OUR LADY OF FATIMA UNIVERSITY

OLFU VISION
A premier inclusive university of choice aspiring to improve man as man by developing individuals through a legacy of excellent education and
compassionate value formation.
OLFU MISSION UNIVERSITY CORE VALUES
The Our Lady of Fatima University, together with Fatima Medical Science A - Aspires to do his Best
Foundation, Inc., is dedicated to the improvement of man as man through
C-C C - Credible and Compassionate
the holistic formation of individuals imbued with knowledge, skills, and H - Hardworking and Honorable
virtues. I - Inspiration to Others
E - Efficient, Effective and Ethical
V - Visionary
E - Entrepreneurial, Employable and Excellent Work Habits 
R - Responsible

PHARMACY PROGRAM VISION PHARMACY PROGRAM MISSION

The College of Pharmacy is committed to preparing students to
The College of Pharmacy envisions being a topnotch provider of excellent become ethical, professionally competent, research and
education to future pharmacy professionals through its compliance with community service-oriented and environmentally conscious
industry standards. pharmacists.

PROGRAM EDUCATIONAL OBJECTIVES  STUDENT LEARNING OUTCOMES 

Three to five years after graduation, a graduate of the Bachelor of Science
in Pharmacy at Our Lady of Fatima University is committed to:
1. practice as successful and licensed pharmacist
2. participate in, or serve as an officer of a local, regional, national
pharmacy organization, to advance professional goals
3. engage in continuous learning and professional development
4. apply managerial and entrepreneurial skills
By the time of graduation, the student should:
1. Demonstrate knowledge and skills required in the
practice of pharmacy
2. Provide Pharmaceutical care
3. Conduct relevant research and disseminate findings
4. Demonstrate efficient and effective management and
entrepreneurial skills
5. Communicate and facilitate effectively
6. Demonstrate understanding of ethical and legal
principles related to the practice of pharmacy
7. Work collaboratively with inter- and multi-professional
teams
8. Demonstrate an ability to understand professional,
ethical, and social responsibilities
9. Recognize the importance of lifelong learning for
pharmacists

COURSE SYLLABUS
COURSE PHCP312
COURSE TITLE Clinical Pharmacy and Pharmacotherapeutics II
CODE
PHCP311
CREDIT UNITS 3-unit lecture, 1-unit laboratory COURSE PREREQUISITE/S/CO-REQUISITE

Lecture: 3 hours lecture per week; 3 hours Third Year, Second

CONTACT
laboratory per week COURSE PLACEMENT Semester
HOURS
Rationale: This course is designed to provide the student with an understanding of the pathophysiology and the therapeutic
strategies for the management of the diseases in the field of cardiology, nephrology, respiratory, cardiology, and
endocrinology.
COURSE Focus: This course covers disease orientation, therapeutic goal setting, pharmacotherapy intervention, documentation, and
DESCRIPTION pharmacotherapy care planning.
Outcomes: At the end of the course, the students are expected to demonstrate competency in formulating pharmacotherapy
interventions, documentation of pharmacotherapy intervention, and pharmacotherapy care plans to deliver the highest
quality of patient-centered care. 
 Essential Learning Constructive Alignment
Content Program Student
Week Declarative Functional Suggested Teaching/ Assessment
Standards Educational Learning
Knowledge Knowledge Learning Activities Tasks
Outcomes Outcomes
Offline:
Module No. 1:
Management of
Respiratory Disorders

Preparation of a
Pharmaceutical Care
Explaining the Formative
Plan
pathophysiology assessment
of the disorder
Online:
Summative
Synchronous
Identifying assessment
- Interactive Lecture
factors that may
induce or Graded
- Case Presentation
Demonstrate potentiate the Recitation
SLO 1
Competence on 1.1 Allergic disorder
PEO 1 SLO 2 Asynchronous
Disease State Rhinitis Preparation of
PEO 2 SLO 5 - Learning Material
1 Management of 1.2 Asthma Describing the Pharmaceutical
PEO 3 SLO 7 (with links to
Respiratory 1.3 COPD clinical Care Plan
SLO 8 videos)
Disorders presentation of
the disorder, SLO 9 Presentation of
- Case Studies
including Pharmaceutical
diagnostic and Care Plan
- Preparation of a
laboratory tests
Pharmaceutical
Major
Care Plan
Evaluating the Examinations
therapeutic
- Small Group
outcomes Discussion on the
Proposed
Pharmaceutical
Care Plan

- Simulations / case
analysis
Formative
assessment
Offline:
Module No. 2: Summative
2.1 Constipation Management of assessment
and Diarrhea Explaining the Gastrointestinal
Demonstrate 2.2 Gastroesoph pathophysiology Disorders Graded
SLO 1
Competence on ageal Reflux of the disorder Recitation
PEO 1 SLO 2
Disease State Disease Preparation of a
PEO 2 SLO 5 Pharmaceutical Care
2 Management of (GERD) Identifying Preparation of
PEO 3 SLO 7 Plan
Gastrointestinal 2.3 Hepatitis, factors that may Pharmaceutical
SLO 8 Care Plan
Disorders Viral induce or
2.4 Inflammatory SLO 9 LABORATORY:
potentiate the
Bowel disorder Exercise 1: Respiratory Presentation of
Disease (IBD) Disorders (Chronic Pharmaceutical
Obstructive Pulmonary Care Plan
Disease)
Major
Examinations
3 Demonstrate 2.5 Nausea and Describing the PEO 1 SLO 1 Online: Formative
Competence on Vomiting clinical PEO 2 SLO 2 Synchronous assessment
Disease State 2.6 Pancreatitis presentation of PEO 3 SLO 5 - Interactive Lecture
Management of 2.7 Peptic Ulcer the disorder, SLO 7 Summative
Gastrointestinal Disease including SLO 8 - Case Presentation assessment
Disorders diagnostic and SLO 9
laboratory tests Asynchronous Graded
Evaluating the - Learning Material Recitation
therapeutic (with links to
outcomes videos) Preparation of
Pharmaceutical
- Case Studies Care Plan

- Preparation of a Presentation of
Pharmaceutical Pharmaceutical
Care Plan Care Plan

- Small Group Major

 Discussion on the
Proposed
Pharmaceutical
Care Plan

- Simulations / case
analysis
Examinations

LABORATORY:
Exercise 2:
Gastrointestinal
Disorders (NSAID-
Induced Ulcer Disease)
Formative
Offline: assessment
Module No. 3:
Management of Summative
Endocrinologic assessment
Explaining the Disorders
Demonstrate pathophysiology Graded
3.1 SLO 1
Competence on of the disorder Preparation of a Recitation
Hyperthyroidism PEO 1 SLO 2 Pharmaceutical Care
Disease State 3.2 PEO 2 SLO 5
4 Management of Identifying Plan Preparation of
Hypothyroidism PEO 3 SLO 7
Endocrinologic factors that may Pharmaceutical
3.3 Growth SLO 8 LABORATORY:
Disorders induce or Care Plan
SLO 9 Exercise 3:
potentiate the
disorder Endocrinologic Disorders Presentation of
(Type 2 Diabetes Pharmaceutical
Mellitus) Care Plan

Post-Lab Exercises 1-3 Major

Examinations
Online:
Synchronous
- Interactive Lecture

- Case Presentation
Formative
Asynchronous assessment
- Learning Material
(with links to Summative
Describing the videos) assessment
clinical
Demonstrate presentation of - Case Studies Graded
SLO 1
Competence on the disorder, Recitation
PEO 1 SLO 2 - Preparation of a
Disease State including
3.4 Reproductive PEO 2 SLO 5 Pharmaceutical
5 Management of 3.5 Diabetes diagnostic and Preparation of
PEO 3 SLO 7 Care Plan
Endocrinologic Mellitus laboratory tests Pharmaceutical
SLO 8 Care Plan
Disorders SLO 9 - Small Group
Evaluating the
therapeutic Discussion on the Presentation of
Proposed Pharmaceutical
outcomes
Pharmaceutical Care Plan
Care Plan
Major
- Simulations / case
Examinations
analysis

LABORATORY:
Laboratory Exam

6 PRELIM EXAMINATION
7 Demonstrate 4.1 ACTH Explaining the PEO 1 SLO 1 Offline: Formative
Competence on Insufficiencie pathophysiology PEO 2 SLO 2 Module No. 4: assessment
Disease State s of the disorder PEO 3 SLO 5 Management of Bone
Management of 4.2 Gout and SLO 7 and Joint Disorders Summative
Bone and Joint Hyperuricem Identifying SLO 8 assessment
Disorders ia factors that may SLO 9 Preparation of a
4.3 Osteoarthriti induce or Pharmaceutical Care Graded
s potentiate the Plan Recitation
disorder
LABORATORY: Preparation of
Exercise 4: Bone and Pharmaceutical
Joint Disorders Care Plan
(Rheumatoid Arthritis)
 Presentation of
Pharmaceutical
Care Plan

Major
Examinations
Online:
Synchronous
- Interactive Lecture

- Case Presentation

Asynchronous Formative
- Learning Material assessment
(with links to
videos) Summative
Describing the assessment
clinical - Case Studies
Demonstrate presentation of Graded
SLO 1 - Preparation of a
Competence on the disorder, Recitation
PEO 1 SLO 2 Pharmaceutical
Disease State including
4.4 Osteoporosis PEO 2 SLO 5 Care Plan
8 Management of 4.5 Rheumatoid diagnostic and Preparation of
PEO 3 SLO 7
Bone and Joint arthritis laboratory tests Pharmaceutical
SLO 8 - Small Group Care Plan
Disorders SLO 9 Discussion on the
Evaluating the
therapeutic Proposed Presentation of
Pharmaceutical Pharmaceutical
outcomes
Care Plan Care Plan

- Simulations / case Major

analysis
Examinations

LABORATORY:
Exercise 5: Metabolic
Disorders
(Hyperlipidemia)

9 Demonstrate Hyperlipidemia Explaining the PEO 1 SLO 1 Offline: Formative

Competence on pathophysiology PEO 2 SLO 2 Module No. 5: assessment
Disease State of the disorder PEO 3 SLO 5 Management of
Management of SLO 7 Metabolic Disorders Summative
Metabolic Identifying SLO 8 assessment
Disorders factors that may SLO 9 Preparation of a
induce or Pharmaceutical Care Graded
potentiate the Plan Recitation
disorder
Online: Preparation of
Describing the Synchronous Pharmaceutical
clinical - Interactive Lecture Care Plan
presentation of
the disorder, - Case Presentation Presentation of
including Pharmaceutical
diagnostic and Asynchronous Care Plan
laboratory tests - Learning Material
(with links to Major
Evaluating the videos) Examinations
therapeutic
outcomes - Case Studies

- Preparation of a
Pharmaceutical
Care Plan

- Small Group
Discussion on the
Proposed
Pharmaceutical
Care Plan

- Simulations / case
analysis

LABORATORY:
Exercise 6: Dermatologic
Disorders (Acne
 Vulgaris)
6.1 Acne vulgaris Offline:
6.2 Psoriasis Module No. 6:
6.3 Skin Management of
disorders Dermatologic Disorders
and
cutaneous Preparation of a
drug Pharmaceutical Care
reactions Plan

Online:
Synchronous
Explaining the
- Interactive Lecture
pathophysiology Formative
of the disorder assessment
- Case Presentation
Identifying Summative
Asynchronous
factors that may assessment
- Learning Material
induce or
(with links to
Demonstrate potentiate the Graded
SLO 1 videos)
Competence on disorder Recitation
PEO 1 SLO 2
Disease State PEO 2 SLO 5 - Case Studies
10 Management of Describing the Preparation of
PEO 3 SLO 7
Dermatologic clinical Pharmaceutical
SLO 8 - Preparation of a
Disorders presentation of Care Plan
SLO 9 Pharmaceutical
the disorder,
Care Plan
including Presentation of
diagnostic and Pharmaceutical
- Small Group
laboratory tests Care Plan
Discussion on the
Proposed
Evaluating the Major
Pharmaceutical
therapeutic Care Plan Examinations
outcomes
- Simulations / case
analysis

LABORATORY:
Exercise 7: Gynecologic
and Obstetric Disorders
(Contraception)

Post Lab Exercise 4-7

11 Demonstrate 7.1 Contraceptio Explaining the PEO 1 SLO 1 Offline: Formative
Competence on n pathophysiology PEO 2 SLO 2 Module No. 7: assessment
Disease State 7.2 Hormone of the disorder PEO 3 SLO 5 Management of
Management of therapy in SLO 7 Gynecologic and Summative
Gynecologic women Identifying SLO 8 Obstetric Disorders assessment
and Obstetric 7.3 Pregnancy factors that may SLO 9
Disorders and induce or Preparation of a Graded
Lactation potentiate the Pharmaceutical Care Recitation
disorder Plan
Preparation of
Describing the Online: Pharmaceutical
clinical Synchronous Care Plan
presentation of - Interactive Lecture
the disorder, Presentation of
including - Case Presentation Pharmaceutical
diagnostic and Care Plan
laboratory tests Asynchronous
- Learning Material Major
Evaluating the (with links to Examinations
therapeutic videos)
outcomes
- Case Studies

- Preparation of a
Pharmaceutical
Care Plan

- Small Group
Discussion on the
Proposed
Pharmaceutical
Care Plan

- Simulations / case
 analysis

LABORATORY:
Laboratory Exam
12 MIDTERM EXAMINATION
Formative
assessment

Offline: Summative
Module No. 8: assessment
Explaining the Management of
pathophysiology Infectious Diseases
Demonstrate SLO 1 Graded
of the disorder
Competence on Recitation
8.1 CNS PEO 1 SLO 2
Disease State Preparation of a
Infections Identifying PEO 2 SLO 5
13 Management of 8.2 HIV / AIDS Pharmaceutical Care Preparation of
factors that may PEO 3 SLO 7 Plan
Infectious Pharmaceutical
8.3 Influenza induce or SLO 8
Diseases Care Plan
potentiate the SLO 9 LABORATORY:
disorder
Exercise 8: Infectious Presentation of
Diseases (Community- Pharmaceutical
Acquired Pneumonia) Care Plan

Major
Examinations
Online:
Synchronous
- Interactive Lecture

- Case Presentation
Formative
Asynchronous
assessment
- Learning Material
(with links to
Summative
Describing the videos)
assessment
clinical
presentation of - Case Studies
Demonstrate SLO 1 Graded
8.4 Upper and the disorder,
Competence on Recitation
Lower including PEO 1 SLO 2 - Preparation of a
Disease State diagnostic and PEO 2 SLO 5 Pharmaceutical
Respiratory Tract
14 Management of Preparation of
Infections laboratory tests PEO 3 SLO 7 Care Plan
Infectious Pharmaceutical
8.5 Sepsis and SLO 8
Diseases - Small Group Care Plan
Septic Shock Evaluating the SLO 9
therapeutic Discussion on the
Presentation of
outcomes Proposed
Pharmaceutical
Pharmaceutical
Care Plan
Care Plan
Major
- Simulations / case
analysis Examinations

LABORATORY:
Exercise 9: Oncologic
Disorders (Breast
Cancer)
Formative
assessment

Summative
Offline:
assessment
Module No. 9:
Explaining the
Management of
Demonstrate pathophysiology Graded
SLO 1 Oncologic Disorders
Competence on 9.1 Breast of the disorder Recitation
PEO 1 SLO 2
Disease State Cancer
PEO 2 SLO 5 Preparation of a
15 Management of 9.2 Colorectal Identifying
PEO 3 SLO 7 Pharmaceutical Care
Preparation of
Oncologic cancer factors that may Pharmaceutical
SLO 8 Plan
induce or Care Plan
Disorders 9.3 Lung cancer SLO 9
potentiate the LABORATORY:
disorder Presentation of
Exercise 10: Prostate
Pharmaceutical
Cancer Care Plan

Major
Examinations
16 Demonstrate Describing the PEO 1 SLO 1 Online: Formative
Competence on 9.4 Lymphomas clinical PEO 2 SLO 2 Synchronous assessment
 - Interactive Lecture

- Case Presentation

Asynchronous
- Learning Material
(with links to
videos)
Summative
- Case Studies assessment

presentation of - Preparation of a Graded

the disorder, Pharmaceutical Recitation
Disease State including Care Plan
SLO 5
Management of 9.5 Prostate diagnostic and Preparation of
PEO 3 SLO 7
Oncologic laboratory tests - Small Group Pharmaceutical
cancer SLO 8 Discussion on the
Disorders Care Plan
Evaluating the SLO 9 Proposed
therapeutic Pharmaceutical Presentation of
outcomes Care Plan Pharmaceutical
Care Plan
- Simulations / case
analysis Major
Examinations

LABORATORY:
Exercise 11:
Immunologic Disorders
(Allergic Drug Reactions)

Post Lab Exercises 8-11

Offline:
Module No. 10:
Immunosuppression
and Management of
Eating Disorders

Preparation of a
Pharmaceutical Care
Plan
Explaining the
pathophysiology Formative
Online:
of the disorder assessment
Synchronous
- Interactive Lecture
Identifying Summative
factors that may assessment
- Case Presentation
induce or
Demonstrate potentiate the Graded
SLO 1 Asynchronous
Competence on 10.1 Immunosup disorder Recitation
PEO 1 SLO 2 - Learning Material
Disease State pression
PEO 2 SLO 5 (with links to
17 Management of Therapy Describing the Preparation of
PEO 3 SLO 7 videos)
Oncologic 10.2 Eating clinical Pharmaceutical
presentation of SLO 8 Care Plan
Disorder Disorders
SLO 9 - Case Studies
the disorder,
including Presentation of
- Preparation of a
diagnostic and Pharmaceutical
Pharmaceutical
laboratory tests Care Plan
Care Plan
Evaluating the Major
- Small Group
therapeutic Examinations
Discussion on the
outcomes Proposed
Pharmaceutical
Care Plan

- Simulations / case
analysis

LABORATORY:
Laboratory Exam
18 FINAL EXAMINATION
 REQUIRED TEXTBOOK

Dipiro, J, et. al. (2020) Pharmacotherapy: A Pathophysiologic Approach 

Schwinghammer, T & Koehler, J. (2017) Pharmacotherapy Casebook: A Patient-Focused Approach 10th Edition
Golan, David E. (2017) Principles of pharmacology : the pathophysiologic basis of drug therapy, 4th ed. Wolters Kluwer
Ford, Susan M. (2017) Roach's introductory clinical pharmacology, 10th ed. Wolters Kluwer
Stoner, Nicola (2017) Oxford Handbook of Clinical Pharmacy. Oxford University Press
Whittlesea, Cate (2018) Clinical Pharmacy and Therapeutics. Elsevier
Blenkinsopp, Alison (2018) Symptoms in the Pharmacy: A Guide to the Management of Common Illnesses. Wiley-Blackwell
Braund, Rhiannon (2020) Renal medicine and clinical pharmacy. Springer. https://bok.asia/book/11224080/bb72aa
Layne, Kerry (2020) 100 Cases in clinical pharmacology, therapeutics and prescribing. CRC Press. https://b-ok.asia/book/5791235/46b8b6
Wani, Mohammad Younus, ed. (2020) Combination therapy against multidrug resistance. Academic Press.
https://bok.asia/book/5585702/ea48a6
Babar , Zaheer-Ud-Din, ed. (2019) Encyclopedia of pharmacy practice and clinical pharmacy. Elsevier.
https://book4you.org/book/16423172/b9d11f
Chisholm-Burns, Marie A., ... [et al.], eds. (2019) Pharmacotherapy principles and practice, 5th ed. McGraw-Hill.
https://book4you.org/book/5902802/aa7f42
Mahmoud, Sherif Hanafy (2019) Patient assessment in clinical pharmacy: a comprehensive guide. Springer.
https://b-ok.asia/book/5585251/2a05be
Thomas, Dixon, ed (2019) Clinical pharmacy education, practice and research. Elsevier. 
https://www.elsevier.com/books/clinical-pharmacy-education-practice-andresearch/thomas/978-0-12-814276-9

REFERENCES (BOOKS/ONLINE WEBSITES/JOURNALS)

Rollins, D.E. & Blumenthal, D. Goodman & Gilman’s Workbook and Casebook for Pharmacological and Basic Therapeutics

ASSESSMENT WEIGHTING: HOMEWORK, WRITTEN REPORTS AND PAPERS

Homework and Assignment Each student will have to submit 9 assignments and 3 discussion boards for the entire semester. 25 equivalent points
Particulars: will be given for every topic which will be part of the assessment tasks.
GRADING SYSTEM
The final grade of the student is interpreted as shown on the table below:
AVERA ABOVE
95 – 97 92-94 89-91 86– 88 83– 85 80-82 76-79 75 74 and below
GE 98.00
FINAL
GRAD 1.00 1.25 1.50 1.75 2.0 2.25 2.50 2.75 3.00 5.0
E
FDA (Failure due to Absences) UW (Unauthorized Withdrawal) INC (Incomplete)
AW (authorized withdrawal NFE (No Final Examination
Lecture 70%: Prelim Exam (20%) Midterm exam (20%) Final exam (20%) Quizzes/Oral Recitation (30%) Research/Assignments/Discussion boards(10%)
Laboratory 30%: Prelim exam 15% Midterm exam 15% Final exam 15% Quizzes 20% Assessment tasks 25% Performance Tasks 10%

OTHER IMPORTANT INFORMATION

Per Section 1551 of CHED’s Manual of Regulation for Private Educational Institution, a student who has incurred absences more than
twenty percent (20%) of the total number of school days shall not be given credit to the course regardless of class standing.
1. Any student, who, during the semester, exceeds the maximum number of absences, whether excused or unexcused, shall be
dropped from the course concerned if he has incurred:
▪ 24 hours of absences in a 6 unit course
▪ 20 hours of absences in a 5 unit course
▪ 16 hours of absences in a 4 unit course
▪ 12 hours of absences in a 3 unit course
ATTENDANCE ▪ 8 hours of absences in a 2 unit course
REQUIREMENTS ▪ 4 hours of absences in a 1 unit course
2. Tardiness of fifteen (15) minutes shall be considered as an absence.
3. Time lost by late enrolment shall be considered as time lost by absence.
4. Excuse from any absence does not absolve the student from compliance with any subject requirement.
5. For our online discussion, you must log in at least five (5) minutes before the designated start of the
session.
For further provisions of the said policy, please refer to the OLFU Student Handbook.

1. SYNCHRONOUS & ASYNCHRONOUS DISCUSSION. All synchronous discussions will be delivered using zoom or google classroom
as the main platform. Some of the discussions will be recorded as part of asynchronous learning.
2. Readings. Class readings will be assigned to provide you with important background information necessary to understand the
class lectures, and to facilitate your participation in the discussions. Class reading assignments are listed in this syllabus and
uploaded in CANVAS. You will be expected to have studied the readings before each class and be prepared to participate actively.
OTHER COURSE 3. Homework /Assignments/Other Assessment Tasks. All students are required to submit all the assignments through Canvas LMS.
REQUIREMENTS/POLICIES 4. Class Participation/Oral Recitation. Students should come to each class prepared to discuss, raise questions, and answer
questions concerning the assigned topic for that day. Student’s preparation and class participation will be assessed each meeting
time through your active participation in oral recitation, class discussion and activities.
5. Academic Dishonesty. Any student who cheats or plagiarizing on any coursework will receive a grade of “zero” on the work in
question.
6. Other policies set by the Instructor.
STUDENTS COURSE All exercises and requirements for the course are to be complied by the students as part of their portfolio and must be made
PORTFOLIO available for inspection by the instructor before the end of the semester
EXAMINATION Quizzes. You need to complete each quiz in one sitting, as there is an allotted time to complete the quiz. You must work
 independently; do not work with others. Use of class materials including the textbook during the quiz is strictly prohibited. Only
registered, enrolled users can take graded quizzes.
*CANVAS can monitor how many times you switched tabs during the facilitation of the quiz. Hence, it would not be wise to
attempt to cheat on such quizzes.
1. No make-up quizzes will be given to students.
2. Major examinations are given only during the scheduled examination period.
3. Removal examination is not allowed by the College.

ONLINE CLASSROOM All students are required to conduct themselves in a professional manner. Students should be on time to class. Disruptive behavior
BEHAVIOR of any sort will not be tolerated
LANGUAGE OF
ENGLISH
INSTRUCTION
FACULTY CONSULTATION
Please see Posted Faculty Consultation Schedule for the current semester
SCHEDULE

PREPARED BY: REVIEWED & APPROVED BY:

Faculty of the College of Pharmacy- OLFU Ms. Olive M. de Vera, RPh. MS Pharm
Date Revised: December 2021 Dean, College of Pharmacy
Date Reviewed:

Contents were based from the PACOP prepared Syllabus

Name of Student: _____________________

Date signed: _________________________